Susan E Graf

CIK 1577637 · Chief Business Officer · last filed 2026-06-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

5

Total Filings

15

Lifetime Open-Market Net

-$306.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CGON Director $59.56 $0 3 2026-06-05
AARD Director $3.90 $0 1 2025-06-13
Finch Therapeutics Group, Inc. (FNCH) Delisted Director 5,010 $7.30 $36.6K $1.4K 3 2023-06-09
Epizyme, Inc. (EPZM) Delisted Chief Business Officer $1.47 $0 3 2018-02-13
NPS PHARMACEUTICALS INC (NPSP) Delisted VP,Corp Development & Strategy 0 -$307.8K 5 2015-02-24

Recent Filings · Page 2 of 2

15 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2015-02-24 NPS PHARMACEUTICALS INC (NPSP) Delisted Mixed −4,761 -$219.0K EDGAR
2015-02-20 NPS PHARMACEUTICALS INC (NPSP) Delisted Mixed +961 -$22.2K EDGAR
2015-02-11 NPS PHARMACEUTICALS INC (NPSP) Delisted Mixed -$207.8K EDGAR
2014-02-14 NPS PHARMACEUTICALS INC (NPSP) Delisted Grant (A) $0 EDGAR
2013-06-18 NPS PHARMACEUTICALS INC (NPSP) Delisted Grant (A) $0 EDGAR
Showing 1115 of 15
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.